论文部分内容阅读
癫健安为一新型广谱抗癫痫药。本组在采用血浓度监测下以本药治疗小儿癫痫68例,总有效率达78％,以强直—阵挛发作及失神发作疗效最好,有效率分别达91％及86％。本文用9个典型病例,说明采用血浓度监测可以了解病者对药物耐受的个体差异,找出临床疗效不好的正确原因而及时排除,正确掌握用药剂量和及时发现服药中的问题。从而达到了提高疗效,减少毒副作用的目的。说明血浓度监测对临床的意义。
Epilepsy is a new type of broad-spectrum antiepileptic drug. The group under the blood concentration monitoring of the drug in children with epilepsy in 68 cases, the total effective rate of 78%, with tonic-clonic seizures and absence of seizures the best, effective rates were 91% and 86%. In this paper, nine typical cases, the use of blood concentration monitoring can understand the individual patient tolerance of the individual differences to find the correct cause of poor clinical efficacy and timely rule out the right dose and timely detection of medication problems. So as to achieve the purpose of improving curative effect and reducing side effects. Description of blood concentration monitoring of clinical significance.